Pasithea Therapeutics (KTTA) Research & Development (2022 - 2024)
Historic Research & Development for Pasithea Therapeutics (KTTA) over the last 3 years, with Q4 2024 value amounting to $1.5 million.
- Pasithea Therapeutics' Research & Development fell 5494.57% to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $7.2 million, marking a year-over-year decrease of 1113.81%. This contributed to the annual value of $7.2 million for FY2024, which is 1113.81% down from last year.
- Pasithea Therapeutics' Research & Development amounted to $1.5 million in Q4 2024, which was down 5494.57% from $1.6 million recorded in Q3 2024.
- Pasithea Therapeutics' 5-year Research & Development high stood at $3.4 million for Q4 2023, and its period low was $1.1 million during Q1 2023.
- In the last 3 years, Pasithea Therapeutics' Research & Development had a median value of $1.6 million in 2023 and averaged $1.9 million.
- Per our database at Business Quant, Pasithea Therapeutics' Research & Development soared by 14172.64% in 2023 and then crashed by 5494.57% in 2024.
- Pasithea Therapeutics' Research & Development (Quarter) stood at $1.4 million in 2022, then skyrocketed by 141.73% to $3.4 million in 2023, then plummeted by 54.95% to $1.5 million in 2024.
- Its last three reported values are $1.5 million in Q4 2024, $1.6 million for Q3 2024, and $2.4 million during Q2 2024.